Related references
Note: Only part of the references are listed.Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
Athanasia Piouka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
S. M. Carlsen et al.
HUMAN REPRODUCTION (2009)
Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids
Isabelle Streuli et al.
FERTILITY AND STERILITY (2008)
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome
Jie Wu et al.
GYNECOLOGICAL ENDOCRINOLOGY (2008)
Metformin for the treatment of the polycystic ovary syndrome
John E. Nestler
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
Asli Somunkiran et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Comparison of ethinyl-estradiol plus cyproterone acetate Versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome
Manuel Luque-Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis
S. Nader et al.
HUMAN REPRODUCTION (2007)
Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries
Laura Pellatt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Serum anti-Mullerian hormone throughout the human menstrual cycle
A. La Marca et al.
HUMAN REPRODUCTION (2006)
Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Anti-Mullerian hormone: a new marker for ovarian function
JA Visser et al.
REPRODUCTION (2006)
Serum mullerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
Y Siow et al.
FERTILITY AND STERILITY (2005)
Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
T Piltonen et al.
HUMAN REPRODUCTION (2005)
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
S Jonard et al.
HUMAN REPRODUCTION UPDATE (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Variation in resistin gene promoter not associated with polycystic ovary syndrome
M Urbanek et al.
DIABETES (2003)
Share Paper
